Wind Profiling in the Lower Atmosphere from Wind-Induced Perturbations to Multirotor UAS.
We present a model-based approach to estimate the vertical profile of horizontal wind velocity components using motion perturbations of a multirotor unmanned aircraft system (UAS) in both hovering and steady ascending flight.
The state estimation framework employed for wind estimation was adapted to a set of closed-loop rigid body models identified for an off-the-shelf quadrotor.
The quadrotor models used for wind estimation were characterized for hovering and steady ascending flight conditions ranging between 0 and 2 m/s. The closed-loop models were obtained using system identification algorithms to determine model structures and estimate model parameters.
The wind measurement method was validated experimentally above the Virginia Tech Kentland Experimental Aircraft Systems Laboratory by comparing quadrotor and independent sensor measurements from a sonic anemometer and two SoDAR instruments.
mPEG-AC,40K |
|||
| 33-MF001009-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-GA,40K |
|||
| 33-MF001012-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-SA,40K |
|||
| 33-MF001013-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-SG,40K |
|||
| 33-MF001027-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-SS,40K |
|||
| 33-MF001028-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-AA,40K |
|||
| 33-MF001121-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,40K |
|||
| 33-MF001004-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-ACA,40K |
|||
| 33-MF001010-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-GAA,40K |
|||
| 33-MF001014-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-MAL,40K |
|||
| 33-MF001022-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-GAS,40K |
|||
| 33-MF001029-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-SAS,40K |
|||
| 33-MF001030-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-NPC,40K |
|||
| 33-MF001034-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-FITC,40K |
|||
| FL001044-40K-100mg | Biochempeg | 100mg | EUR 475.2 |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-OPSS,40K |
|||
| 33-MF001035-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-DSPE,40K |
|||
| 33-MF001096-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-Biotin,40K |
|||
| 33-MF001041-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-Epoxide,40K |
|||
| 33-MF001021-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-Hydrazide,40K |
|||
| 33-MF001019-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Mal-PEG-OH, 40K |
|||
| HE022002-40K | Biochempeg | Inquire | Ask for price |
Mal-PEG-SC, 40K |
|||
| HE022023-40K | Biochempeg | Inquire | Ask for price |
4-ArmPEG-SG,40K |
|||
| 33-A44027-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
4-ArmPEG-SS,40K |
|||
| 33-A44028-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-OH,40K |
|||
| 33-A88002-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-SH,40K |
|||
| 33-A88003-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-GA,40K |
|||
| 33-A88012-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-SA,40K |
|||
| 33-A88013-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-SG,40K |
|||
| 33-A88027-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-SS,40K |
|||
| 33-A88028-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
6-ArmPEG-OH, 40K |
|||
| A66002-40K | Biochempeg | Inquire | Ask for price |
8-ArmPEG-GAA,40K |
|||
| 33-A88014-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-SAA,40K |
|||
| 33-A88015-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-MAL,40K |
|||
| 33-A88022-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-SCM,40K |
|||
| 33-A88024-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-GAS,40K |
|||
| 33-A88029-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-SAS,40K |
|||
| 33-A88030-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-NPC,40K |
|||
| 33-A88034-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
4-ArmPEG-NH2, 40K |
|||
| A44005-40K | Biochempeg | Inquire | Ask for price |
4-ArmPEG-Acid,40K |
|||
| 33-A44017-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-Acid,40K |
|||
| 33-A88017-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
SH-PEG-NH2HCl, 40K |
|||
| HE003005-40K | Biochempeg | Inquire | Ask for price |
SH-PEG-Biotin, 40K |
|||
| HE003041-40K | Biochempeg | Inquire | Ask for price |
8-ArmPEG-Azide,40K |
|||
| 33-A88006-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-AlKyne,40K |
|||
| 33-A88007-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-Epoxide,40K |
|||
| 33-A88021-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-Acrylate,40K |
|||
| 33-A88009-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-Acrylamide,40K |
|||
| 33-A88010-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
pGEX-4T3-ITLN1(35-313aa)-K198L |
|||
| PVT39628 | Nova Lifetech | 2ug | EUR 280 |
SARS-CoV-2 S protein (F817P, A892P, A899P, A942P, K986P, V987P), His Tag (MALS verified) |
|||
| SPN-C52Hd | ACROBIOSYSTEMS | 50ug | EUR 3389.9 |
|
Description: SARS-CoV-2 S protein, His Tag (SPN-C52Hd) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession # QHD43416.1). Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein. |
|||
SARS-CoV-2 S protein (F817P, A892P, A899P, A942P, K986P, V987P), His Tag (MALS verified) |
|||
| SPN-C52Hd-500ug | ACROBIOSYSTEMS | 500ug | EUR 3389.9 |
|
Description: SARS-CoV-2 S protein, His Tag (SPN-C52Hd) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession # QHD43416.1). Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein. |
|||
SARS-CoV-2 S protein (F817P, A892P, A899P, A942P, K986P, V987P), His Tag (MALS verified) |
|||
| SPN-C52Hd-50ug | ACROBIOSYSTEMS | 50ug | EUR 490.5 |
|
Description: SARS-CoV-2 S protein, His Tag (SPN-C52Hd) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession # QHD43416.1). Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein. |
|||
pGEX-4T3-ITLN1(35-313aa)-K198L-Y297F |
|||
| PVT39629 | Nova Lifetech | 2ug | EUR 280 |
Recombinant SARS-CoV-2 Spike (S1+S2 ECD) (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P) [His] |
|||
| DAGC360 | Creative Diagnostics | 1 mg | EUR 2257.5 |
|
Description: Recombinant |
|||
pLVX-AcGFP-N1-AR(del 79-80/470-473aa;G373R/W797R/K862E) |
|||
| PPL00559-4a | Bioworld Biotech | 2745bp | EUR 218 |
|
Description: pLVX-AcGFP1-N1 |
|||
Y-shape-PEG-NH-Mal, 40K |
|||
| YS001022-40K | Biochempeg | Inquire | Ask for price |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)-His Recombinant Protein |
|||
| E45O54920M2-100 | EnoGene | 100 ug | EUR 1574.9 |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)-His Recombinant Protein |
|||
| MBS8123745-01mg | MyBiosource | 0.1mg | EUR 560 |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)-His Recombinant Protein |
|||
| MBS8123745-5x01mg | MyBiosource | 5x0.1mg | EUR 2370 |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P) -His Recombinant Protein |
|||
| PO54920M2 | Leading Biology | 100 µg | Ask for price |
H3N2/HA (R157K, T219K, K342R), 18-344aa, H3N2/HA (Canine), His tag, Baculovirus |
|||
| MBS204646-002mg | MyBiosource | 0.02mg | EUR 215 |
H3N2/HA (R157K, T219K, K342R), 18-344aa, H3N2/HA (Canine), His tag, Baculovirus |
|||
| MBS204646-01mg | MyBiosource | 0.1mg | EUR 340 |
H3N2/HA (R157K, T219K, K342R), 18-344aa, H3N2/HA (Canine), His tag, Baculovirus |
|||
| MBS204646-05mg | MyBiosource | 0.5mg | EUR 765 |
H3N2/HA (R157K, T219K, K342R), 18-344aa, H3N2/HA (Canine), His tag, Baculovirus |
|||
| MBS204646-5x05mg | MyBiosource | 5x0.5mg | EUR 3195 |
40K Cryogenic Freezer With CS200 Controller |
|||
| TW-LABS40K-CS | MiTeGen | 1 UNIT | EUR 41579 |
|
Description: 40K Cryogenic Freezer With CS200 Controller |
|||
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)-His Recombinant HEK293 Cell Lysate (WB positive control) |
|||
| MBS8119651-03mg | MyBiosource | 0.3mg | EUR 280 |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)-His Recombinant HEK293 Cell Lysate (WB positive control) |
|||
| MBS8119651-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) |
|||
| 053-29 | PHOENIX PEPTIDE | 200 μg | EUR 140.4 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) |
|||
| 053-28 | PHOENIX PEPTIDE | 200 μg | EUR 140.4 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - EIA Kit |
|||
| EK-053-28 | PHOENIX PEPTIDE | 96 wells | EUR 603.72 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - RIA Kit |
|||
| RK-053-28 | PHOENIX PEPTIDE | 125 tubes | EUR 932.04 |
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| ABM40369-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A monoclonal antibody for detection of Acetyl NF kB P65 K314/K315) from Human, Mouse, Rat. This Acetyl NF kB P65 K314/K315) antibody is for IHC-P. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide of Acetyl NF kB P65 (K314/K315) |
|||
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| ABM40369-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A monoclonal antibody for detection of Acetyl NF kB P65 K314/K315) from Human, Mouse, Rat. This Acetyl NF kB P65 K314/K315) antibody is for IHC-P. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide of Acetyl NF kB P65 (K314/K315) |
|||
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| ABM40369-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A monoclonal antibody for detection of Acetyl NF kB P65 K314/K315) from Human, Mouse, Rat. This Acetyl NF kB P65 K314/K315) antibody is for IHC-P. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide of Acetyl NF kB P65 (K314/K315) |
|||
Acetyl NF kB P65(K314/K315) Mouse Monoclonal Antibody(2A11) |
|||
| HW206 | SAB | 100ul | EUR 319 |
Acetyl NF kB P65(K314/K315) Mouse Monoclonal Antibody(2A11) |
|||
| HW206-100ul | SAB | 100ul | EUR 302.4 |
Acetyl NF kB P65(K314/K315) Mouse Monoclonal Antibody(2A11) |
|||
| E12-722 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Acetyl NF kB P65(K314/K315) Mouse Monoclonal Antibody(2A11) |
|||
| E11-123754 | EnoGene | 100ug/100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Acetyl NF kB P65(K314/K315) Mouse Monoclonal Antibody(2A11) |
|||
| E44H11348 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| MBS8528897-01mg | MyBiosource | 0.1mg | EUR 305 |
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| MBS8528897-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| MBS8528897-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| MBS8528897-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| MBS8528897-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| MBS9428984-005mL | MyBiosource | 0.05mL | EUR 245 |
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| MBS9428984-01mL | MyBiosource | 0.1mL | EUR 305 |
Acetyl NF kB P65 (K314/K315) Mouse Monoclonal Antibody (2A11) |
|||
| MBS9428984-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
Acetyl NF kB P65(K314 K315) Mouse Monoclonal Antibody(2A11) |
|||
| RA10212-100ul | Reed Biotech | 100 ul | EUR 298 |
Acetyl NF kB P65(K314 K315) Mouse Monoclonal Antibody(2A11) |
|||
| RA10212-50ul | Reed Biotech | 50 ul | EUR 198 |
Acetyl NF kB P65(K314/K315) mouse Monoclonal Antibody(2A11) |
|||
| UB-GEN-1147 | UpingBio | 100 ul | EUR 200 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Antibody |
|||
| H-053-29 | PHOENIX PEPTIDE | 100 μl | EUR 399.6 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - FAM Labeled |
|||
| FG-053-29A | PHOENIX PEPTIDE | 1 nmol | EUR 267.84 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - FITC Labeled |
|||
| FG-053-29B | PHOENIX PEPTIDE | 1 nmol | EUR 267.84 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Cy3 Labeled |
|||
| FC3-053-29 | PHOENIX PEPTIDE | 1 nmol | EUR 497.88 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Cy5 Labeled |
|||
| FC5-053-29 | PHOENIX PEPTIDE | 1 nmol | EUR 497.88 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - I-125 Labeled |
|||
| T-053-29 | PHOENIX PEPTIDE | 10 μCi | EUR 1145.88 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Biotin Labeled |
|||
| B-053-28 | PHOENIX PEPTIDE | 10 μg | EUR 267.84 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Biotin Labeled |
|||
| B-053-29 | PHOENIX PEPTIDE | 10 μg | EUR 267.84 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Antibody |
|||
| H-053-28 | PHOENIX PEPTIDE | 100 μl | EUR 399.6 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Fluorescent EIA Kit |
|||
| FEK-053-29 | PHOENIX PEPTIDE | 96 wells | EUR 660.96 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - FAM Labeled |
|||
| FG-053-28A | PHOENIX PEPTIDE | 1 nmol | EUR 267.84 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - FITC Labeled |
|||
| FG-053-28B | PHOENIX PEPTIDE | 1 nmol | EUR 267.84 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Cy3 Labeled |
|||
| FC3-053-28 | PHOENIX PEPTIDE | 1 nmol | EUR 497.88 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Cy5 Labeled |
|||
| FC5-053-28 | PHOENIX PEPTIDE | 1 nmol | EUR 497.88 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - I-125 Labeled |
|||
| T-053-28 | PHOENIX PEPTIDE | 10 μCi | EUR 1145.88 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - FAM Labeled Purified IgG |
|||
| FG-G-053-28A | PHOENIX PEPTIDE | 100 μl | EUR 469.8 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - FAM Labeled Purified IgG |
|||
| FG-G-053-29A | PHOENIX PEPTIDE | 100 μl | EUR 469.8 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - FITC Labeled Purified IgG |
|||
| FG-G-053-29B | PHOENIX PEPTIDE | 100 μl | EUR 469.8 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Purified IgG Antibody |
|||
| G-053-28 | PHOENIX PEPTIDE | 100 μg | EUR 399.6 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Purified IgG Antibody |
|||
| G-053-29 | PHOENIX PEPTIDE | 100 μg | EUR 370.44 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Cy3 Labeled Purified IgG |
|||
| FC3-G-053-28 | PHOENIX PEPTIDE | 100 μl | EUR 756 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Cy3 Labeled Purified IgG |
|||
| FC3-G-053-29 | PHOENIX PEPTIDE | 100 μl | EUR 756 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Cy5 Labeled Purified IgG |
|||
| FC5-G-053-28 | PHOENIX PEPTIDE | 100 μl | EUR 756 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Cy5 Labeled Purified IgG |
|||
| FC5-G-053-29 | PHOENIX PEPTIDE | 100 μl | EUR 756 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - EIA Kit, extraction-free |
|||
| EK-053-29 | PHOENIX PEPTIDE | 96 wells | EUR 603.72 |
Hepatitis Be Ag, Recombinant, 17kD, 160aa (HBeAg) |
|||
| MBS637130-01mg | MyBiosource | 0.1mg | EUR 820 |
Hepatitis Be Ag, Recombinant, 17kD, 160aa (HBeAg) |
|||
| MBS637130-5x01mg | MyBiosource | 5x0.1mg | EUR 3530 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Biotin Labeled Purified IgG |
|||
| B-G-053-28 | PHOENIX PEPTIDE | 100 μl | EUR 469.8 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Biotin Labeled Purified IgG |
|||
| B-G-053-29 | PHOENIX PEPTIDE | 100 μl | EUR 469.8 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - FITC Labeled Purified IgG |
|||
| FG-G-053-28B | PHOENIX PEPTIDE | 100 μl | EUR 469.8 |
Catestatin (K388R,A395G,P403L) Variant / prepro-K388R,A395G,P403L Chromogranin A (Rat) - Rhodamine Labeled Purified IgG |
|||
| FR-G-053-29 | PHOENIX PEPTIDE | 100 μl | EUR 531.36 |
Catestatin (K385R,A329G,P400L) Variant / prepro-K385R,A392G,P400L Chromogranin A (Mouse) - Rhodamine Labeled Purified IgG |
|||
| FR-G-053-28 | PHOENIX PEPTIDE | 100 μl | EUR 531.36 |
SNAP-25 (Synaptosomal-associated protein 25kDa), 1-207aa, C.elegans, E Coli |
|||
| MBS203012-002mg | MyBiosource | 0.02mg | EUR 190 |
SNAP-25 (Synaptosomal-associated protein 25kDa), 1-207aa, C.elegans, E Coli |
|||
| MBS203012-01mg | MyBiosource | 0.1mg | EUR 280 |
SNAP-25 (Synaptosomal-associated protein 25kDa), 1-207aa, C.elegans, E Coli |
|||
| MBS203012-05mg | MyBiosource | 0.5mg | EUR 570 |
SNAP-25 (Synaptosomal-associated protein 25kDa), 1-207aa, C.elegans, E Coli |
|||
| MBS203012-5x05mg | MyBiosource | 5x0.5mg | EUR 2325 |
K-252a (SF 2370, Antibiotic K 252a, Antibiotic SF 2370) |
|||
| MBS651357-01mg | MyBiosource | 0.1mg | EUR 375 |
K-252a (SF 2370, Antibiotic K 252a, Antibiotic SF 2370) |
|||
| MBS651357-1mg | MyBiosource | 1mg | EUR 535 |
K-252a (SF 2370, Antibiotic K 252a, Antibiotic SF 2370) |
|||
| MBS651357-5x1mg | MyBiosource | 5x1mg | EUR 2250 |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 (D80A, K417N, E484K, N501Y, D614G, A701V) Protein (ECD, His Tag) |
|||
| E45O54617I2-100 | EnoGene | 100 ug | EUR 1217.4 |
Recombinant SARS-CoV-2 Spike S1+S2 ECD (D80A, K417N, E484K, N501Y, D614G, A701V)(His Tag) |
|||
| MBS2567818-01mg | MyBiosource | 0.1mg | EUR 1015 |
Recombinant SARS-CoV-2 Spike S1+S2 ECD (D80A, K417N, E484K, N501Y, D614G, A701V)(His Tag) |
|||
| MBS2567818-5x01mg | MyBiosource | 5x0.1mg | EUR 4550 |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 (D80A, K417N, E484K, N501Y, D614G, A701V) Protein (ECD, His Tag) |
|||
| MBS8122272-01mg | MyBiosource | 0.1mg | EUR 560 |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 (D80A, K417N, E484K, N501Y, D614G, A701V) Protein (ECD, His Tag) |
|||
| MBS8122272-5x01mg | MyBiosource | 5x0.1mg | EUR 2370 |
Recombinant SARS-CoV-2 Spike S1+S2 ECD (D80A, K417N, E484K, N501Y, D614G, A701V)(His Tag) |
|||
| PKSV030360-100ug | Elabscience Biotech | 100ug | EUR 1105 |
|
Description: SARS-CoV-2 |
|||
SARS-CoV-2 (2019-nCoV) Spike S1+S2 (D80A, K417N, E484K, N501Y, D614G, A701V) Protein (ECD, His Tag) |
|||
| PH0169M27 | Leading Biology | 100 µg | Ask for price |
SARS-CoV-2 (2019-nCoV) Spike S1+S2 (D80A, K417N, E484K, N501Y, D614G, A701V) Protein (ECD, His Tag) |
|||
| PO54617I2 | Leading Biology | 100 µg | Ask for price |
Recombinant (E.coli) purified Rabies Virus (MRV/Genotype 1) Matrix 2 protein (full length ~1-202aa; ~22kda, >95%, his-tag) |
|||
| RBM2P15-R-10 | Alpha Diagnostics | 25 | EUR 534 |
A-804598 ?(A 804598; A804598) |
|||
| MBS131368-100mg | MyBiosource | 100mg | EUR 1495 |
Ubiquitin K48 (5A14) Rabbit Monoclonal Antibody |
|||
| E28M0743 | EnoGene | 100ul | EUR 295 |
A330070K13Rik (untagged) - Mouse RIKEN cDNA A330070K13 gene (A330070K13Rik) |
|||
| MC225707 | Origene Technologies GmbH | 10 µg | Ask for price |
A430033K04Rik (untagged) - Mouse RIKEN cDNA A430033K04 gene (A430033K04Rik), (10ug) |
|||
| MC205471 | Origene Technologies GmbH | 10 µg | Ask for price |
A530054K11Rik (untagged) - Mouse RIKEN cDNA A530054K11 gene (A530054K11Rik), (10ug) |
|||
| MC222924 | Origene Technologies GmbH | 10 µg | Ask for price |
A230046K03Rik (untagged) - Mouse RIKEN cDNA A230046K03 gene (A230046K03Rik), (10ug) |
|||
| MC223843 | Origene Technologies GmbH | 10 µg | Ask for price |
A230046K03Rik (GFP-tagged) - Mouse RIKEN cDNA A230046K03 gene (A230046K03Rik), (10ug) |
|||
| MG216903 | Origene Technologies GmbH | 10 µg | Ask for price |
A930009A15Rik (untagged) - Mouse RIKEN cDNA A930009A15 gene (A930009A15Rik) |
|||
| MC225721 | Origene Technologies GmbH | 10 µg | Ask for price |
A630023A22Rik (untagged) - Mouse RIKEN cDNA A630023A22 gene (A630023A22Rik) |
|||
| MC226246 | Origene Technologies GmbH | 10 µg | Ask for price |
A230046K03Rik (Myc-DDK-tagged) - Mouse RIKEN cDNA A230046K03 gene (A230046K03Rik) |
|||
| MR216903 | Origene Technologies GmbH | 10 µg | Ask for price |
A430033K04Rik (Myc-DDK-tagged) - Mouse RIKEN cDNA A430033K04 gene (A430033K04Rik) |
|||
| MR209903 | Origene Technologies GmbH | 10 µg | Ask for price |
A330070K13Rik (myc-DDK-tagged) - Mouse RIKEN cDNA A330070K13 gene (A330070K13Rik) |
|||
| MR227918 | Origene Technologies GmbH | 10 µg | Ask for price |
A930009A15Rik (myc-DDK-tagged) - Mouse RIKEN cDNA A930009A15 gene (A930009A15Rik) |
|||
| MR227932 | Origene Technologies GmbH | 10 µg | Ask for price |
A630023A22Rik (myc-DDK-tagged) - Mouse RIKEN cDNA A630023A22 gene (A630023A22Rik) |
|||
| MR228457 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of A230046K03Rik (mGFP-tagged) - Mouse RIKEN cDNA A230046K03 gene (A230046K03Rik) |
|||
| MR216903L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of A430033K04Rik (mGFP-tagged) - Mouse RIKEN cDNA A430033K04 gene (A430033K04Rik) |
|||
| MR209903L4 | Origene Technologies GmbH | 10 µg | Ask for price |
2610528A11Rik (untagged) - Mouse RIKEN cDNA 2610528A11 gene (2610528A11Rik) |
|||
| MC225525 | Origene Technologies GmbH | 10 µg | Ask for price |
2010109A12Rik (untagged) - Mouse RIKEN cDNA 2010109A12 gene (2010109A12Rik) |
|||
| MC225725 | Origene Technologies GmbH | 10 µg | Ask for price |
4930591A17Rik (untagged) - Mouse RIKEN cDNA 4930591A17 gene (4930591A17Rik) |
|||
| MC225783 | Origene Technologies GmbH | 10 µg | Ask for price |
4930557A04Rik (untagged) - Mouse RIKEN cDNA 4930557A04 gene (4930557A04Rik) |
|||
| MC225790 | Origene Technologies GmbH | 10 µg | Ask for price |
4930447A16Rik (untagged) - Mouse RIKEN cDNA 4930447A16 gene (4930447A16Rik) |
|||
| MC225815 | Origene Technologies GmbH | 10 µg | Ask for price |
4930468A15Rik (untagged) - Mouse RIKEN cDNA 4930468A15 gene (4930468A15Rik) |
|||
| MC226316 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of A230046K03Rik (Myc-DDK-tagged) - Mouse RIKEN cDNA A230046K03 gene (A230046K03Rik) |
|||
| MR216903L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of A430033K04Rik (Myc-DDK-tagged) - Mouse RIKEN cDNA A430033K04 gene (A430033K04Rik) |
|||
| MR209903L3 | Origene Technologies GmbH | 10 µg | Ask for price |
3830417A13Rik (GFP-tagged) - Mouse RIKEN cDNA 3830417A13 gene (3830417A13Rik) |
|||
| MG204251 | Origene Technologies GmbH | 10 µg | Ask for price |
4930444A02Rik (GFP-tagged) - Mouse RIKEN cDNA 4930444A02 gene (4930444A02Rik) |
|||
| MG205284 | Origene Technologies GmbH | 10 µg | Ask for price |
8430410A17Rik (GFP-tagged) - Mouse RIKEN cDNA 8430410A17 gene (8430410A17Rik) |
|||
| MG205366 | Origene Technologies GmbH | 10 µg | Ask for price |
2310022A10Rik (GFP-tagged) - Mouse RIKEN cDNA 2310022A10 gene (2310022A10Rik) |
|||
| MG206523 | Origene Technologies GmbH | 10 µg | Ask for price |
2810408A11Rik (GFP-tagged) - Mouse RIKEN cDNA 2810408A11 gene (2810408A11Rik) |
|||
| MG206938 | Origene Technologies GmbH | 10 µg | Ask for price |
1700011A15Rik (GFP-tagged) - Mouse RIKEN cDNA 1700011A15 gene (1700011A15Rik) |
|||
| MG201439 | Origene Technologies GmbH | 10 µg | Ask for price |
6330408A02Rik (GFP-tagged) - Mouse RIKEN cDNA 6330408A02 gene (6330408A02Rik) |
|||
| MG210944 | Origene Technologies GmbH | 10 µg | Ask for price |
1810009A15Rik (GFP-tagged) - Mouse RIKEN cDNA 1810009A15 gene (1810009A15Rik) |
|||
| MG200627 | Origene Technologies GmbH | 10 µg | Ask for price |
1700012A03Rik (GFP-tagged) - Mouse RIKEN cDNA 1700012A03 gene (1700012A03Rik) |
|||
| MG200737 | Origene Technologies GmbH | 10 µg | Ask for price |
1700006A11Rik (untagged) - Mouse RIKEN cDNA 1700006A11 gene (1700006A11Rik), (10ug) |
|||
| MC218432 | Origene Technologies GmbH | 10 µg | Ask for price |
2810403A07Rik (untagged) - Mouse RIKEN cDNA 2810403A07 gene (2810403A07Rik), (10ug) |
|||
| MC219737 | Origene Technologies GmbH | 10 µg | Ask for price |
2900026A02Rik (untagged) - Mouse RIKEN cDNA 2900026A02 gene (2900026A02Rik), (10ug) |
|||
| MC213163 | Origene Technologies GmbH | 10 µg | Ask for price |
6330403A02Rik (untagged) - Mouse RIKEN cDNA 6330403A02 gene (6330403A02Rik), (10ug) |
|||
| MC214702 | Origene Technologies GmbH | 10 µg | Ask for price |
9430007A20Rik (untagged) - Mouse RIKEN cDNA 9430007A20 gene (9430007A20Rik), (10ug) |
|||
| MC214720 | Origene Technologies GmbH | 10 µg | Ask for price |
4930444A02Rik (untagged) - Mouse RIKEN cDNA 4930444A02 gene (4930444A02Rik), (10ug) |
|||
| MC204007 | Origene Technologies GmbH | 10 µg | Ask for price |
2810408A11Rik (untagged) - Mouse RIKEN cDNA 2810408A11 gene (2810408A11Rik), (10ug) |
|||
| MC204876 | Origene Technologies GmbH | 10 µg | Ask for price |
6330408A02Rik (untagged) - Mouse RIKEN cDNA 6330408A02 gene (6330408A02Rik), (10ug) |
|||
| MC205254 | Origene Technologies GmbH | 10 µg | Ask for price |
1700011A15Rik (untagged) - Mouse RIKEN cDNA 1700011A15 gene (1700011A15Rik), (10ug) |
|||
| MC210328 | Origene Technologies GmbH | 10 µg | Ask for price |
4933417A18Rik (untagged) - Mouse RIKEN cDNA 4933417A18 gene (4933417A18Rik), (10ug) |
|||
| MC210430 | Origene Technologies GmbH | 10 µg | Ask for price |
1110032A03Rik (untagged) - Mouse RIKEN cDNA 1110032A03 gene (1110032A03Rik), (10ug) |
|||
| MC210785 | Origene Technologies GmbH | 10 µg | Ask for price |
1700008A04Rik (untagged) - Mouse RIKEN cDNA 1700008A04 gene (1700008A04Rik), (10ug) |
|||
| MC210904 | Origene Technologies GmbH | 10 µg | Ask for price |
1700018A14Rik (untagged) - Mouse RIKEN cDNA 1700018A14 gene (1700018A14Rik), (10ug) |
|||
| MC210927 | Origene Technologies GmbH | 10 µg | Ask for price |
1700019A02Rik (untagged) - Mouse RIKEN cDNA 1700019A02 gene (1700019A02Rik), (10ug) |
|||
| MC210929 | Origene Technologies GmbH | 10 µg | Ask for price |
2300009A05Rik (untagged) - Mouse RIKEN cDNA 2300009A05 gene (2300009A05Rik), (10ug) |
|||
| MC210941 | Origene Technologies GmbH | 10 µg | Ask for price |
4930505A04Rik (untagged) - Mouse RIKEN cDNA 4930505A04 gene (4930505A04Rik), (10ug) |
|||
| MC211586 | Origene Technologies GmbH | 10 µg | Ask for price |
1700012A03Rik (untagged) - Mouse RIKEN cDNA 1700012A03 gene (1700012A03Rik), (10ug) |
|||
| MC211725 | Origene Technologies GmbH | 10 µg | Ask for price |
4930427A07Rik (untagged) - Mouse RIKEN cDNA 4930427A07 gene (4930427A07Rik), (10ug) |
|||
| MC212107 | Origene Technologies GmbH | 10 µg | Ask for price |
4930430A15Rik (untagged) - Mouse RIKEN cDNA 4930430A15 gene (4930430A15Rik), (10ug) |
|||
| MC216674 | Origene Technologies GmbH | 10 µg | Ask for price |
Comparison results demonstrated quadrotor wind estimation in close agreement with the independent wind velocity measurements. However, horizontal wind velocity profiles were difficult to validate using time-synchronized SoDAR measurements.
Analysis of the noise intensity and signal-to-noise ratio of the SoDARs proved that close-proximity quadrotor operations can corrupt wind measurement from SoDARs, which has not previously been reported.